Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 7/20 | 0.62 |
| ▸ | HTR1B | P28222 | 6/20 | 0.62 |
| ▸ | FYN | P06241 | 1/20 | 0.59 |
| ▸ | DRD2 | P14416 | 3/20 | 0.55 |
| ▸ | DRD3 | P35462 | 3/20 | 0.55 |
| ▸ | DRD4 | P21917 | 2/20 | 0.55 |
| ▸ | HTR1A | P08908 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CASP1 | P29466 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7439062 | 0.91 | FYN (0.54) | HTR1DHTR1BFYNDRD3HTR1A | |
| SCHEMBL7441326 | 0.84 | HTR1D (0.58) | HTR1DHTR1BFYNDRD2DRD3 | |
| SCHEMBL7443837 | 0.79 | HTR1D (0.59) | HTR1DHTR1BFYNDRD2DRD3 | |
| SCHEMBL7443957 | 0.79 | HTR1D (0.48) | HTR1DHTR1BFYNDRD2DRD3 | |
| SCHEMBL8315482 | 0.77 | HTR1D (1.00) | HTR1DHTR1B | |
| SCHEMBL8486515 | 0.76 | FYN (0.74) | FYNDRD2DRD3DRD4HTR1A | |
| SCHEMBL7445563 | 0.76 | HTR1D (0.56) | HTR1DHTR1BDRD2DRD3DRD4 | |
| SCHEMBL17193468 | 0.76 | DRD2 (0.70) | DRD2DRD3 | |
| SCHEMBL7434651 | 0.75 | HTR1D (0.83) | HTR1DHTR1BDRD2 | |
| SCHEMBL7437054 | 0.75 | HTR1D (0.60) | HTR1DHTR1BDRD2DRD3DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0690843-B1 | Formyl- or cyano- substituted indole derivatives having dopaminergic activity | UPJOHN CO (US) | 2000-08-30 | — | — | EP | disclosed |
| WO-1997046553-A1 | THROMBIN INHIBITORS | NOVARTIS AG (CH) | 1997-12-11 | — | — | WO | disclosed |
| US-5639778-A | TREATING CENTRAL NERVOUS SYSTEM DISORDERS | PHARMACIA & UPJOHN COMPANY (US) | 1997-06-17 | — | — | US | disclosed |
| EP-0690843-A1 | INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY | PHARMACIA & UPJOHN COMPANY (US) | 1996-01-10 | — | — | EP | disclosed |
| WO-1994021608-A1 | INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY | THE UPJOHN COMPANY (US) | 1994-09-29 | — | — | WO | disclosed |